摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 929039-04-3

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
929039-04-3
化学式
C22H19ClFNO5S
mdl
——
分子量
463.914
InChiKey
HCZOCFIJVMXTGP-CYBMUJFWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.12
  • 重原子数:
    31.0
  • 可旋转键数:
    5.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    82.44
  • 氢给体数:
    0.0
  • 氢受体数:
    6.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    sodium hydroxide 作用下, 以 四氢呋喃 为溶剂, 以50%的产率得到LI7K2MH2IJ
    参考文献:
    名称:
    In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites
    摘要:
    Metabolites of the potent DP antagonist, MK-0524, were generated using in vitro systems including hepatic microsomes and hepatocytes. Four metabolites (two hydroxylated diastereomers, a ketone and an acyl glucuronide) were characterized by LC-MS/MS and H-1 NMR. Larger quantities of these metabolites were prepared by either organic synthesis or biosynthetically to be used as standards in other studies. The propensity for covalent binding was assessed and was found to be acceptable (< 50 pmol-equiv/mg protein). (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.10.055
  • 作为产物:
    参考文献:
    名称:
    In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites
    摘要:
    Metabolites of the potent DP antagonist, MK-0524, were generated using in vitro systems including hepatic microsomes and hepatocytes. Four metabolites (two hydroxylated diastereomers, a ketone and an acyl glucuronide) were characterized by LC-MS/MS and H-1 NMR. Larger quantities of these metabolites were prepared by either organic synthesis or biosynthetically to be used as standards in other studies. The propensity for covalent binding was assessed and was found to be acceptable (< 50 pmol-equiv/mg protein). (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.10.055
点击查看最新优质反应信息